✦ LIBER ✦

Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder

✍ Scribed by David L. Dunner; Michael Wilson; Maurizio Fava; Susan Kornstein; Rodrigo Munoz; John O'Reardon; Madhukar Trivedi; Madelaine Wohlreich

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 121 KB
Volume: 25
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.20339

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term effectiveness of cognitive the

Long-term effectiveness of cognitive therapy in major depressive disorder

✍ Paula L. Hensley; Deepa Nadiga; E.H. Uhlenhuth 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

Duloxetine for the treatment of major de

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation

✍ Madelaine M. Wohlreich; Craig H. Mallinckrodt; Apurva Prakash; John G. Watkin; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

The combination of duloxetine and buprop

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

✍ George I. Papakostas; John J. Worthington III; Dan V. Iosifescu; Gustavo Kinrys; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission

Safety and tolerability of duloxetine in

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

✍ James I. Hudson; Madelaine M. Wohlreich; Daniel K. Kajdasz; Craig H. Mallinckrod 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## Objective To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD). ## Method Safety data were integrated from the acute phases of eight double‐blind, placebo‐controlled trials in which patients were random

Long-term tolerability of tetrabenazine

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders

✍ Christopher Kenney; Christine Hunter; Joseph Jankovic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract We sought to review the long‐term tolerability of tetrabenazine (TBZ) and seek determinants of tolerability in the treatment of hyperkinetic movement disorders. A retrospective chart review was performed on patients treated with TBZ between 1997 and 2004. Efficacy of TBZ was assessed by

Effectiveness and tolerability of paroxe

Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open-label, prospective, multi-center trial in Korea

✍ Chi-Un Pae; Won-Myong Bahk; Duk-In Jon; Sang-Yeol Lee; Bo-Hyun Yoon; Kyung Joon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract ## Objectives This study evaluated the effectiveness and tolerability of paroxetine controlled release (CR) for the treatment of Korean patients with major depressive disorder (MDD) in a naturalistic treatment setting. ## Methods One hundred and ninety patients with MDD were enrolled